106 related articles for article (PubMed ID: 16437457)
1. Cotrimoxazole prophylaxis for opportunistic infections in children with HIV infection.
Grimwade K; Swingler GH
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD003508. PubMed ID: 16437457
[TBL] [Abstract][Full Text] [Related]
2. Estimating the impact of alternative programmatic cotrimoxazole strategies on mortality among children born to mothers with HIV: A modelling study.
Mathur S; Smuk M; Evans C; Wedderburn CJ; Gibb DM; Penazzato M; Prendergast AJ
PLoS Med; 2024 Feb; 21(2):e1004334. PubMed ID: 38377150
[TBL] [Abstract][Full Text] [Related]
3. Cotrimoxazole Prophylaxis Increases Resistance Gene Prevalence and α-Diversity but Decreases β-Diversity in the Gut Microbiome of Human Immunodeficiency Virus-Exposed, Uninfected Infants.
D'Souza AW; Moodley-Govender E; Berla B; Kelkar T; Wang B; Sun X; Daniels B; Coutsoudis A; Trehan I; Dantas G
Clin Infect Dis; 2020 Dec; 71(11):2858-2868. PubMed ID: 31832638
[TBL] [Abstract][Full Text] [Related]
4. Childhood malnutrition: toward an understanding of infections, inflammation, and antimicrobials.
Jones KD; Thitiri J; Ngari M; Berkley JA
Food Nutr Bull; 2014 Jun; 35(2 Suppl):S64-70. PubMed ID: 25069296
[TBL] [Abstract][Full Text] [Related]
5. The effect of cotrimoxazole coadministrated with antituberculous drugs on serum transaminases in HIV-infected adults from the Ivory Coast.
Messou E; Anglaret X; Bonard D; Kouabena H; N'Dri-Yoman T; Dosso M; Dabis F;
Br J Clin Pharmacol; 2001 Nov; 52(5):611-2. PubMed ID: 11736872
[No Abstract] [Full Text] [Related]
6. Translating evidence into policy in low-income countries: lessons from co-trimoxazole preventive therapy.
Hutchinson E; Droti B; Gibb D; Chishinga N; Hoskins S; Phiri S; Parkhurst J
Bull World Health Organ; 2011 Apr; 89(4):312-6. PubMed ID: 21479096
[TBL] [Abstract][Full Text] [Related]
7. Cotrimoxazole Prophylaxis Selects for Antimicrobial Resistance in Human Immunodeficiency Virus-Exposed, Uninfected Infants.
Bourke CD; Evans C
Clin Infect Dis; 2020 Dec; 71(11):2869-2871. PubMed ID: 31832637
[No Abstract] [Full Text] [Related]
8. Long-term non-progression and risk factors for disease progression among children living with HIV in Botswana and Uganda: A retrospective cohort study.
Kyobe S; Kisitu G; Mwesigwa S; Farirai J; Katagirya E; Retshabile G; Williams L; Mirembe A; Ketumile L; Wayengera M; Mukisa J; Sebetso G; Diphoko T; Amujal M; Kigozi E; Katabazi F; Oceng R; Mlotshwa B; Morapedi K; Nsangi B; Wampande E; Tsimako M; Brown C; Kasvosve I; Joloba M; Anabwani G; Mpoloka S; Mardon G; Kekitiinwa A; Hanchard NA; Kyosiimire-Lugemwa J; Matshaba M; Kiragga D;
Int J Infect Dis; 2024 Feb; 139():132-140. PubMed ID: 38036259
[TBL] [Abstract][Full Text] [Related]
9. Co-trimoxazole prophylaxis for children who are HIV-exposed and uninfected: a systematic review.
Wedderburn CJ; Evans C; Slogrove AL; Rehman AM; Gibb DM; Prendergast AJ; Penazzato M
J Int AIDS Soc; 2023 Jun; 26(6):e26079. PubMed ID: 37292018
[TBL] [Abstract][Full Text] [Related]
10. Projected impact and cost-effectiveness of community-based versus targeted azithromycin administration strategies for reducing child mortality in sub-Saharan Africa.
Brander RL; Weaver MR; Pavlinac PB; John-Stewart GC; Hawes SE; Walson JL
Clin Infect Dis; 2020 Jan; 74(3):375-86. PubMed ID: 31905386
[TBL] [Abstract][Full Text] [Related]
11. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants.
Ewing AC; King CC; Wiener JB; Chasela CS; Hudgens MG; Kamwendo D; Tegha G; Hosseinipour MC; Jamieson DJ; Van der Horst C; Kourtis AP
AIDS; 2017 Nov; 31(18):2455-2463. PubMed ID: 28926409
[TBL] [Abstract][Full Text] [Related]
12. Challenges facing effective implementation of co-trimoxazole prophylaxis in children born to HIV-infected mothers in the public health facilities.
Kamuhabwa AA; Manyanga V
Drug Healthc Patient Saf; 2015; 7():147-56. PubMed ID: 26604825
[TBL] [Abstract][Full Text] [Related]
13. Interventions to Improve Neonatal Health and Later Survival: An Overview of Systematic Reviews.
Lassi ZS; Middleton PF; Crowther C; Bhutta ZA
EBioMedicine; 2015 Aug; 2(8):985-1000. PubMed ID: 26425706
[TBL] [Abstract][Full Text] [Related]
14. HIV-TB co-infection in children: associated factors and access to HIV services in Lagos, Nigeria.
Daniel OJ; Adejumo OA; Gidado M; Abdur-Razzaq HA; Jaiyesimi EO
Public Health Action; 2015 Sep; 5(3):165-9. PubMed ID: 26399285
[TBL] [Abstract][Full Text] [Related]
15. Essential interventions: implementation strategies and proposed packages of care.
Lassi ZS; Kumar R; Mansoor T; Salam RA; Das JK; Bhutta ZA
Reprod Health; 2014; 11 Suppl 1(Suppl 1):S5. PubMed ID: 25178110
[TBL] [Abstract][Full Text] [Related]
16. Essential interventions for child health.
Lassi ZS; Mallick D; Das JK; Mal L; Salam RA; Bhutta ZA
Reprod Health; 2014; 11 Suppl 1(Suppl 1):S4. PubMed ID: 25177974
[TBL] [Abstract][Full Text] [Related]
17. Pneumocystis pneumonia in South African children diagnosed by molecular methods.
Morrow BM; Samuel CM; Zampoli M; Whitelaw A; Zar HJ
BMC Res Notes; 2014 Jan; 7():26. PubMed ID: 24410938
[TBL] [Abstract][Full Text] [Related]
18. Concordance of effects of medical interventions on hospital admission and readmission rates with effects on mortality.
Hemkens LG; Contopoulos-Ioannidis DG; Ioannidis JP
CMAJ; 2013 Dec; 185(18):E827-37. PubMed ID: 24144601
[TBL] [Abstract][Full Text] [Related]
19. The role of co-infections in mother-to-child transmission of HIV.
King CC; Ellington SR; Kourtis AP
Curr HIV Res; 2013 Jan; 11(1):10-23. PubMed ID: 23305198
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
